Welcome to kongre.net
Speaker
Scientist, Ajinomoto Bio-Pharma Services
Tomohiro Watanabe, Scientist at Ajinomoto Bio-Pharma Services, spoke at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Enabling Next-Generation Targeted Protein Degradation through AJICAP® Site-Specific Conjugation and Linker Technologies”.
26–29 Oct 2026Boston, United States of America
Professor, Harvard Medical School
President & Chief Executive Officer, Arvinas, Inc.
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Associate Director, Medicinal Chemistry, AstraZeneca
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
These are kept as separate profiles because the programmes give no evidence that they are the same person.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Tomohiro Watanabe, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].